Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pyxis Oncology, Inc.

1.35
+0.11008.87%
Post-market: 1.30-0.0500-3.70%18:13 EDT
Volume:620.87K
Turnover:822.91K
Market Cap:83.63M
PE:-0.86
High:1.36
Open:1.26
Low:1.26
Close:1.24
Loading ...
Jul 27, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 11, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 30, 2023

Major Issues Report

Form 8-K - Current report
Jun 30, 2023

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jun 29, 2023

Correspondence

Form CORRESP - Correspondence
Jun 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 14, 2023

Major Issues Report

Form 8-K - Current report
Jun 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2023

Business Combinations

Form 425 - Prospectuses and communications, business combinations
May 25, 2023

Business Combinations

Form 425 - Prospectuses and communications, business combinations
May 25, 2023

Major Issues Report

Form 8-K - Current report
May 25, 2023

Business Combinations

Form 425 - Prospectuses and communications, business combinations
May 24, 2023

Business Combinations

Form 425 - Prospectuses and communications, business combinations
May 24, 2023

Business Combinations

Form 425 - Prospectuses and communications, business combinations
May 24, 2023

Major Issues Report

Form 8-K - Current report
May 24, 2023

Business Combinations

Form 425 - Prospectuses and communications, business combinations
May 11, 2023

Major Issues Report

8-K - Current report
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]